SHERIDAN, WYOMING – November 06, 2024 – GE HealthCare's Omni Legend, a cutting-edge positron emission tomography/computed tomography (PET/CT) system, is making significant strides in advancing precision care throughout the United States and Canada. With its 100th installation recently completed at the UW Health Eastpark Medical Center in Madison, Wisconsin, and the establishment of its first North American production line in Waukesha, Wisconsin, GE HealthCare is solidifying its commitment to providing innovative imaging technologies that enhance patient outcomes.
Revolutionizing Medical Imaging
The Omni Legend represents a significant leap forward in medical imaging technology. Its advanced digital processing and artificial intelligence (AI) capabilities provide clinicians with valuable insights for informed clinical decision-making, leading to improved patient care.
"We are committed to enabling the broad adoption of precision care across care areas and practice of more personalized medicine, including theranostics,” says Jay Hill, Vice President, Advanced Technology, GE HealthCare. “Individualizing patient care and advanced diagnosis and therapies can help put patients on the right path, sooner — all with the goal of improving patient outcomes."
Enhancing Diagnostic Capabilities
The Omni Legend's exceptional image quality plays a crucial role in early diagnosis and treatment planning. Its high-resolution imaging capabilities enable clinicians to detect small lesions and other abnormalities with greater accuracy, potentially leading to earlier intervention and improved treatment outcomes.
"Medical imaging is a crucial tool for diagnosing disease, identifying a course of treatment, and determining whether therapy is successful for millions of patients in the U.S., Canada, and around the world," states the GE HealthCare press release. "Image quality matters — to the clinician and the patient — making the difference between finding a small lesion early or in its later stages, potentially affecting patient outcomes and disease management."
Meeting the Growing Demand for PET/CT Imaging
The demand for PET/CT imaging has increased dramatically in recent years, driven by advancements in medical research, particularly in oncology and neurology. The Omni Legend is designed to meet this growing demand, offering a scalable solution that can adapt to the evolving needs of healthcare systems.
"With the evolution of medical research, particularly in oncology and neurology, early diagnosis and treatment capabilities are expanding at a rapid rate," the press release states. "Many of these diagnostic and tracking protocols rely heavily on medical imaging, which means we have seen a dramatic rise in demand for PET/CT platforms and services, as well."
Supporting the Wisconsin BioHealth Tech Hub
The production of Omni Legend at GE HealthCare's Waukesha facility aligns with the Wisconsin BioHealth Tech Hub's mission to lead in personalized medicine. This initiative aims to leverage the state's healthcare assets to expand manufacturing, data sharing, and lab space while advancing breakthroughs in genomics, imaging, and big data analytics.
"Already, our Waukesha facility supports these efforts as a vital founding partner in the Wisconsin BioHealth Tech Hub for the development, production and delivery of next-generation imaging technology to increase diagnostic applications," says Hill. "Our team is working with the Tech Hub to support our shared goals of integrating of digital tools and individualized datasets from patients with these new technologies to take personalized medicine to a whole new level, and with the help of clinicians throughout the United States and Canada, increase the yield and value of diagnostics."
Conclusion
GE HealthCare's Omni Legend PET/CT system is transforming the landscape of medical imaging, providing clinicians with the tools they need to deliver precision care to patients. With its exceptional image quality, scalability, and commitment to advancing personalized medicine, the Omni Legend is poised to play a pivotal role in improving healthcare outcomes for years to come.